Will a Committee Lead to Reduced Drug Prices in the United States
The idea of an independent review board to regulate drug prices is gaining ground. Although pharmaceutical companies protest such a committee, pointing at lost innovation, many in the US support a Health Technology Assessment (HTA) committee. This support has become increasingly bipartisan.
“President Biden could take the framework of the former health secretary Alex Azar’s international reference pricing model for Medicare, and give more power to an independent review board.” Read more here.
(Source: Austin Frakt, The Incidental Economist, 02/12/21)